Medicare Enrolled
Dr. Roberto Montoya Barraza, MD
Hematology & Oncology · Rolling Meadows, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Montoya Barraza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Montoya Barraza?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Montoya Barraza
Dr. Roberto Montoya Barraza is a hematology & oncology specialist in Rolling Meadows, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Montoya Barraza performed 59,667 Medicare services across 3,004 unique beneficiaries.
Between the years covered by Open Payments, Dr. Montoya Barraza received a total of $25,639 from 77 pharmaceutical and/or device companies across 431 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Montoya Barraza is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 18% volume in IL
$25,639 industry payments
Medicare Practice Summary
Medicare Utilization ↗59,667
Medicare services
Top 18% in IL for hematology & oncology
3,004
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,140 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
25,500 | $1 | $2 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
17,250 | $2 | $9 |
| Injection, granisetron, extended-release, 0.1 mg | 5,500 | $6 | $10 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,735 | $0 | $2 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,600 | $8 | $55 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
966 | $10 | $65 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
924 | $94 | $290 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
525 | $139 | $335 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
513 | $9 | $40 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
376 | $13 | $74 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
343 | $7 | $70 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
340 | $11 | $68 |
| Anti-nausea injection (ondansetron/Zofran) | 332 | $0 | $9 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
329 | $107 | $488 |
| Iron level test | 292 | $6 | $50 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
292 | $8 | $35 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
283 | $6 | $48 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
275 | $23 | $135 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
249 | $61 | $176 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
216 | $1 | $6 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
177 | $53 | $230 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
167 | $23 | $129 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
115 | $13 | $85 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
104 | $7 | $55 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
102 | $1 | $6 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
100 | $19 | $100 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
97 | $16 | $93 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
96 | $53 | $249 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
87 | $3 | $10 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
87 | $10 | $65 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
78 | $1 | $12 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
60 | $4 | $20 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
60 | $65 | $165 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
53 | $15 | $80 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
50 | $140 | $429 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
50 | $2 | $18 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
44 | $1 | $7 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
42 | $27 | $189 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
41 | $5 | $30 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
38 | $8 | $55 |
| PSA test (prostate cancer screening) | 37 | $18 | $97 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
36 | $4 | $35 |
| New patient office visit, complex (60-74 min) | 24 | $157 | $495 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $67 | $190 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
20 | $98 | $260 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
19 | $13 | $78 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $127 | $390 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
44.5% high complexity
44.2% medium
11.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,639
Total received (2018-2024)
Avg $3,663/year across 7 years
Top 18% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
431
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,144 (35.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,821 (34.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,982 (27.2%)
Other
Charitable contributions, space rental, and other categories
$692 (2.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,987
2023
$7,981
2022
$2,453
2021
$1,307
2020
$205
2019
$2,716
2018
$1,992
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SANOFI-AVENTIS U.S. LLC
$4,350
Janssen Biotech, Inc.
$1,950
Novartis Pharmaceuticals Corporation
$373
Pharmacosmos Therapeutics Inc.
$285
PFIZER INC.
$255
E.R. Squibb & Sons, L.L.C.
$241
Celgene Corporation
$226
ASD Specialty Healthcare, LLC
$192
Merck Sharp & Dohme LLC
$184
ABBVIE INC.
$148
Genentech USA, Inc.
$78
Takeda Pharmaceuticals U.S.A., Inc.
$72
Daiichi Sankyo Inc.
$63
Celltrion USA Inc.
$50
Gilead Sciences, Inc.
$44
BeiGene USA, Inc.
$43
GlaxoSmithKline, LLC.
$41
AstraZeneca Pharmaceuticals LP
$40
TAIHO ONCOLOGY, INC.
$33
GE HEALTHCARE
$32
Deciphera Pharmaceuticals Inc.
$29
Mirati Therapeutics, Inc.
$26
Stemline Therapeutics Inc.
$26
Amneal Pharmaceuticals LLC
$26
GENZYME CORPORATION
$26
Blueprint Medicines Corporation
$25
Eisai Inc.
$24
EMD Serono, Inc.
$24
Janssen Scientific Affairs, LLC
$23
SERVIER PHARMACEUTICALS LLC
$22
Azurity Pharmaceuticals, Inc.
$19
ARRAY BIOPHARMA INC
$16
Top 3 companies account for 74.3% of 2024 payments
All-time payments by company (2018-2024) ›
SANOFI-AVENTIS U.S. LLC
$4,432
Puma Biotechnology, Inc.
$2,998
AstraZeneca Pharmaceuticals LP
$2,510
Janssen Biotech, Inc.
$2,272
PFIZER INC.
$1,927
Novartis Pharmaceuticals Corporation
$1,139
JAZZ PHARMACEUTICALS INC.
$1,100
E.R. Squibb & Sons, L.L.C.
$900
Genentech USA, Inc.
$683
Celgene Corporation
$524
Incyte Corporation
$384
Merck Sharp & Dohme LLC
$353
Takeda Pharmaceuticals U.S.A., Inc.
$339
Amgen Inc.
$317
Lilly USA, LLC
$301
NOVARTIS PHARMACEUTICALS CORPORATION
$299
Seagen Inc.
$292
Pharmacosmos Therapeutics Inc.
$285
Gilead Sciences, Inc.
$275
Novocure GmbH
$250
ASD Specialty Healthcare, LLC
$245
Seattle Genetics, Inc.
$228
Daiichi Sankyo Inc.
$227
ABBVIE INC.
$209
GENZYME CORPORATION
$176
G1 Therapeutics, Inc.
$175
BeiGene USA, Inc.
$168
Astellas Pharma US Inc
$164
Bayer HealthCare Pharmaceuticals Inc.
$164
Merck Sharp & Dohme Corporation
$159
EMD Serono, Inc.
$158
Janssen Scientific Affairs, LLC
$148
AbbVie, Inc.
$130
GlaxoSmithKline, LLC.
$94
Genentech, Inc.
$90
Pharmacyclics LLC, an AbbVie Company
$72
Pharmacyclics LLC, An AbbVie Company
$70
Eisai Inc.
$68
Blueprint Medicines Corporation
$68
Janssen Pharmaceuticals, Inc
$68
SERVIER PHARMACEUTICALS LLC
$62
Alnylam Pharmaceuticals Inc.
$56
TAIHO ONCOLOGY, INC.
$56
Amneal Pharmaceuticals LLC
$53
Stemline Therapeutics Inc.
$53
Celltrion USA Inc.
$50
EISAI INC.
$48
Mirati Therapeutics, Inc.
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$46
TerSera Therapeutics LLC
$40
Alexion Pharmaceuticals, Inc.
$40
ARRAY BIOPHARMA INC
$39
CTI BioPharma Corp.
$37
GE HEALTHCARE
$32
Adaptive Biotechnologies Corporation
$31
Bayer Healthcare Pharmaceuticals Inc.
$31
PharmaEssentia USA Corporation
$30
Deciphera Pharmaceuticals Inc.
$29
SOBI, INC
$29
Helsinn Therapeutics (U.S.), Inc.
$28
Kite Pharma, Inc.
$25
PUMA BIOTECHNOLOGY, INC.
$24
Melinta Therapeutics, LLC
$24
Lexicon Pharmaceuticals, Inc.
$23
Otsuka America Pharmaceutical, Inc.
$23
Karyopharm Therapeutics Inc.
$22
Acrotech Biopharma LLC
$22
ImmunoGen, Inc.
$21
Allergan Inc.
$20
Azurity Pharmaceuticals, Inc.
$19
Dova Pharmaceuticals
$19
INSYS Therapeutics Inc
$19
AbbVie Inc.
$18
Midatech Pharma US Inc
$17
Verastem, Inc.
$17
TOLMAR Pharmaceuticals, Inc.
$14
Tactile Systems Technology Inc
$13
Top 3 companies account for 38.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · BAVENCIO · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CALQUENCE · COSELA · Copiktra · DARZALEX · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · EMEND · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Elahere · Enhertu · Erleada · FLEXITOUCH · FRUZAQLA · Fabhalta · GAMMAGARD · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAYPIRCA · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · Nerlynx · Neulasta · Nplate · OJJAARA · ONUREG · OPDIVO · OPDUALAG · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rezzayo · SANDOSTATIN · SARCLISA · SCEMBLIX · SPRYCEL · SUTENT · SYNDROS · Stivarga · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TEPMETKO · TEVIMBRA · TRUSELTIQ · TUKYSA · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · VEGZELMA · VENCLEXTA · VERZENIO · VIVIMUSTA · Vanflyta · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XPOVIO · XYNTHA · Xermelo · Xospata · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · Zuplenz · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (36%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Hematology & oncology specialists within 10 mi
274
Per 100K population
5.3
County median income
$81,797
Nearest hospital
NORTHWEST COMMUNITY HOSPITAL 1
1.9 mi
1.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Montoya Barraza is a mixed practice specialist, with above-average Medicare volume (top 18% in IL), with mixed engagement industry engagement in the top 18% of IL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Montoya Barraza experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Montoya Barraza performed 25,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Montoya Barraza receive payments from pharmaceutical companies?
Yes. Dr. Montoya Barraza received a total of $25,639 from 77 companies across 431 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Montoya Barraza's costs compare to other hematology & oncology specialists in Rolling Meadows?
Dr. Montoya Barraza's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Montoya Barraza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Rolling Meadows
Browse hematology & oncology specialists in Rolling Meadows ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
Puma Biotechnology, Inc. Payments to Doctors
See all physicians who received payments from Puma Biotechnology, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology